企業分析レポート

バリアン:医療機器企業分析レポート
Varian Medical Device Company Intelligence Report


お電話でのお問い合わせは044-952-0102

概要(日本語)

医薬品や医療機器市場の最先端ビジネスの調査分析で定評を得ているEspicom Business Intelligence(本社:イギリス)では、世界の医療機器の企業詳細情報を企業別にまとめた調査報告書" Medical Devices Company Intelligence Reports "を発行いたしております。

当報告書では、放射線癌治療統合システムにて定評のある米国・カリフォルニアに本拠を置く バリアン・メディカル・システム(Varian Medical Systems)社に焦点をあてて、合併・買収、協定、売却、重大な売買契約、訴訟などを含めた企業の起源から最新の企業活動に至る詳細な企業分析を提供いたします。

主な目次には、バリアン・メディカル・システム社の製品、国際活動、R&D、5年間の完全かつ詳細な財務分析などが含まれます。報告書には見直しに便利な詳細目次が掲載されております。

本レポートの概略は、下記のような内容で提供されております。

  • 概要
  • バリアン・メディカル・システム社の沿革
  • 企業構造
  • 製品
  • 国際活動
  • 研究開発
  • 財務分析

原文

Abstract

Varian Medical Systems (VMS), headquartered in Palo Alto, California, USA, designs and manufactures integrated equipment and software for treating cancer with radiation therapy, as well as radiosurgery and brachytherapy products, X-ray tubes for original equipment manufacturers, replacement X-ray tubes and flat panel imaging detectors. The company also offers a range of products for the industrial and non-destructive testing markets which are not covered by this profile.

VMS has manufacturing facilities in the US, Switzerland, France, the UK, Finland, Germany, Japan and Canada. The company is also building a new plant in Beijing, China, to manufacture linear accelerators and has recently expanded manufacturing capacity in the US for its X-ray products business.

VMS' medical products are classified into three categories: Oncology Systems, X-ray Products and Other, including the Security and Inspection Products (SIP) business and the Ginzton Technology Center (GTC). At the beginning of fiscal 2006, VMS separated SIP from Oncology Systems and reported it with GTC under the Other category. Concurrently, it moved the brachytherapy unit from the Other category to Oncology Systems.

The Oncology Systems segment is VMS' largest, accounting for 83% of the company' s revenue in fiscal 2006, while the X-ray Products unit generated 14% of sales and Other revenue accounted for 4%. Of the company' s 3,900 employees in fiscal 2006, 2,983 were based in the Oncology Systems division and 564 at X-ray Products.

This company report provides:

Executive Summary

An overview of the company, including operating activities, at a glance key events and strategic focus.

Product Portfolio and R&D

The product section of the report focuses on the key aspects of the company' s portfolio and technology, covering core products, key brands, new products and analysis of the competition. Sales data, market size and future potential is included where available.

International Activities

The company' s business activities by geographic region and country.

Appendices

  • Financial Indicators
  • Key corporate events
  • Mergers & acquisitions
  • Joint Ventures
  • Minority Investments
  • Divestitures
  • Agreements
  • Litigation

Table of Contents

EXECUTIVE SUMMARY

  • OVERVIEW
    • Recent Key Events
  • Operating Analysis
    • Fig.1: Percentage of Revenue by Segment, 2006
    • Latest Results
  • STRATEGIC FOCUS
    • ACCEL Instruments and Proton Radiotherapy
    • Market Dynamics
  • PRODUCT PORTFOLIO AND R&D
    • Fig.2: Revenue by Operating Segment, 2004-2006 (US$ million)
    • Recent Product Approvals
  • ONCOLOGY SYSTEMS
  • Financial Performance
    • Oncology Systems' Operating Results, 2004-2006 (US$ million)
    • Oncology Systems' Revenue by Geographic Region, 2004-2006 (US$ million)
      • Fig.3: Oncology Systems' Revenue by Geographic Location, 2006
  • Market Opportunity
  • Competition
  • Products and Technology
  • Inspiration Environment
  • DART
  • IGRT and the On-Board Imager
    • Cone Beam CT Imaging
  • SmartBeam IMRT
  • Linear Accelerators
    • Trilogy Linear Accelerators
    • Clinac Linear Accelerators
  • Respiratory Gating System
  • SonArray
  • Multileaf Collimators
  • Planning, Simulation and Verification Products
    • Eclipse
    • Acuity
    • Exact Treatment Couches
    • PortalVision
  • Imaging for Planning - See and Treat Cancer Care
  • Argus QA Products
  • Oncology Information Management
    • ARIA Oncology Information System
  • Image-Guided Radiosurgery
    • Trilogy Stereotactic System
      • Trilogy Tx
  • Brachytherapy Products
    • Fig.4: VMS' Brachytherapy Sales, 1998-2006 (US$ million)*
    • Image-Guided Brachytherapy - Acuity Brachytherapy Suite
    • BrachyVision 6.5
      • Vitesse 2.0
    • VariSeed 7.1
    • GammaMedplus
    • VariSource 200
    • SmartSeed
    • Applicators and Accessories
  • X-RAY PRODUCTS
    • Financial Performance
    • Market Opportunity
      • X-ray Products' Operating Results, 2004-2006 (US$ million)
      • X-ray Products' Revenue by Geographic Region, 2004-2006 (US$ million)
        • Fig.5: X-ray Products' Revenue by Geographic Region, 2006
      • Digital Radiography Products
      • PaxScan 1313
      • PaxScan 2020
      • PaxScan 2520
      • PaxScan 3030
      • PaxScan 4030A
      • PaxScan 4030CB
      • PaxScan 4030R
    • X-ray Tubes
  • OTHER PRODUCTS
    • Other Division Operating Results, 2004-2006 (US$ million)
  • RESEARCH AND DEVELOPMENT
    • Fig.6: R&D Spending by Division, 2006*
    • Research Establishments
      • Ginzton Technology Center
      • Varian Biosynergy
    • Research Projects
      • Oncology Systems
      • X-ray Products
      • GTC

INTERNATIONAL ACTIVITIES

  • Revenue and Long-lived Assets by Region, 2004-2006 (US$ million)
    • Fig.7: Percentage of Revenue by Geographic Region, 2006
    • Fig.8: Long-Lived Assets by Geographic Region, 2006
    • Fig.9: Oncology Systems' Revenue by Region, 2004-2006 (US$ million)
    • Fig.10: X-ray Products' Revenue by Region, 2004-2006 (US$ million)
  • OPERATING LOCATIONS
    • United States
    • Europe
      • Finland
      • France
      • Germany
      • Switzerland
      • UK
    • ASIA
      • China
      • Japan
      • Manufacturing Locations

APPENDICES

  • APPENDIX 1 - FINANCIAL INDICATORS
  • APPENDIX 2 - KEY CORPORATE EVENTS
  • APPENDIX 3 - MERGERS AND ACQUISITIONS
    • Key Mergers & Acquisitions
    • ACCEL Instruments GmbH
    • Sigma Micro Informatique Conseil
    • OpTx
    • Mitsubishi Electric Company' s Radiotherapy and Service Business
    • Zmed
    • Nippon Oncology Systems
    • MRW
    • MDS Nordion' s HDR Brachytherapy Business
    • Argus Software
    • High Energy Services' Hi-RAD Product Line
    • Multimedia Medical Systems' Therapy Planning Systems Division
    • CyberNisty
    • GE Medical Systems' Radiotherapy Service and Support Organisation
    • Eureka X-ray Tube
    • Interay International X-ray Tube
    • Machlett Laboratories
  • APPENDIX 4 - JOINT VENTURES
    • Varian Medical Systems KK
  • APPENDIX 5 - MINORITY INVESTMENTS
    • dpiX Holding LLC
  • APPENDIX 6 - DIVESTITURES
    • Thin Film Systems Business
    • Electron Devices Business
  • APPENDIX 7 - AGREEMENTS
    • Key Mergers & Acquisitions
    • Resonant Medical
    • BrainLAB
    • Xoft
    • Onco Inc
    • Imaging Sciences International
    • Xoran Technologies
    • NSI Software
    • MED-TEC
    • Toshiba Medical Systems and Sanko Medical Systems
    • Hologic
    • GE Healthcare
    • Hitachi Medical
    • OEM Agreements
    • Supply Agreements
      • UK Department of Health
      • Consorta
      • MedAssets Supply Chain Systems
      • Florida Hospital
      • AmeriNet
      • University of Texas MD Anderson Cancer Center
      • Mid Atlantic Group Network of Shared Services (MAGNET)
      • US Department of Veterans Affairs
  • APPENDIX 8 - LITIGATION
    • Resonant Medical

INDEX OF TABLES

  • Recent Key Events
  • Recent Product Approvals
  • Oncology Systems' Operating Results, 2004-2006 (US$ million)
  • Oncology Systems' Revenue by Geographic Region, 2004-2006 (US$ million)
  • X-ray Products' Operating Results, 2004-2006 (US$ million)
  • X-ray Products' Revenue by Geographic Region, 2004-2006 (US$ million)
  • Other Division Operating Results, 2004-2006 (US$ million)
  • Revenue and Long-lived Assets by Region, 2004-2006 (US$ million)
  • Manufacturing Locations
  • Key Mergers & Acquisitions
  • Key Mergers & Acquisitions

INDEX OF CHARTS

  • Fig.1: Percentage of Revenue by Segment, 2006
  • Fig.2: Revenue by Operating Segment, 2004-2006 (US$ million)
  • Fig.3: Oncology Systems' Revenue by Geographic Location, 2006
  • Fig.4: VMS' Brachytherapy Sales, 1998-2006 (US$ million)*
  • Fig.5: X-ray Products' Revenue by Geographic Region, 2006
  • Fig.6: R&D Spending by Division, 2006*
  • Fig.7: Percentage of Revenue by Geographic Region, 2006
  • Fig.8: Long-Lived Assets by Geographic Region, 2006
  • Fig.9: Oncology Systems' Revenue by Region, 2004-2006 (US$ million)
  • Fig.10: X-ray Products' Revenue by Region, 2004-2006 (US$ million)

商品情報

商品コード:ES13956

出版日:2010年8月

言語:英語

ページ情報:
Pages: 38


(C) Copyright 2003-2012
Global Information, Inc. All rights reserved.